Table 3.
Variable | NPC n=15 |
PC n=13 |
P | NPD n=35 |
PD n=40 |
P | NPH n=40 |
PH n=59 |
P | NPO n=52 |
PO n=67 |
P | NPPre/M n=35 |
PPre/M n=39 |
P |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GI | 1.14±0.31 | 1.45±0.04 | * | 1.07±0.35 | 1.38±0.38 | * | |||||||||
PD (mm) | 2.68±0.34 | 3.02±0.65 | * | 2.50±0.47 | 3.05±0.06 | * | 2.60±0.38 | 3.10±0.64 | * | ||||||
CAL (mm) | 2.56±023 | 3.04±0.54 | * | 2.52±0.39 | 3.44±0.92 | * | 2.68±0.34 | 3.39±0.92 | * | 2.50±0.47 | 3.40±0.83 | * | 2.60±0.38 | 3.28±0.76 | * |
SBI | 1.92±0.56 | 2.53±0.07 | * | 1.76±0.69 | 2.44±0.77 | * | |||||||||
DMFT† | 14.33±8.71 | 16.01±7.84 | 13.89±6.69 | 15.18±0.75 | |||||||||||
FBG‡,§ (mg/dl) | 86.77±5.11 | 95.60±8.17 | * | 229.20±179.8 | 200.06±89.76 | 106.27±49.10 | 169.86±93.61 | * | 97.67±18.43 | 156.64±8.19 | * | 98.40±37.80 | 136.56±73.54 | * | |
TRG& (mg/dl) | 93.42±5.23 | 228.33±80.16 | 162.00±88.57 | 171.50±103.11 | 129.31±82.08 | 181.29±81.59 | * | ||||||||
Vit D¶ (nmol/l) | 69.45±29.31 | 24.65±2.18 | 33.84±12.65 | 31.01±18.03 | |||||||||||
Ne/Ly | 2.05±1.31 | 2.56±1.50 | * | ||||||||||||
LXA4 (pg/ml) | 0.153±0.02 | 0.205±0.05 | * | 0.141±0.03 | 0.163±0.04 | * |
Statistically significant difference between the groups P<0.05;
statistically significant difference among PH and PPost/M groups (P<0.05);
statistically significant difference among NPD and NPC, NPO, NPH groups (P<0.05);
statistically significant difference among PD and PO, PPost/M groups (P<0.05);
statistically significant difference among NPC and NPH, NPD groups (P<0.05);
statistically significant difference among NPC and NPH, NPO groups (P<0.05).